Health News

Adalimumab, a drug often prescribed for women with Crohn’s disease, actively crosses the placenta during the final trimester of pregnancy and remains in a newborn’s bloodstream for at least three months, researchers at the University of California San Francisco have found.

Read more

Filed under: Pharmacy News
Tags: Drug, Pharmacy, Pregnancy

Related posts

• Valproate exposure during pregnancy can impair a child’s cognitive development (0)
  Three-year-olds whose mothers took the antiepileptic drug valproate during pregnancy had average IQs six to nine points lower than children exposed to three other antiepileptic drugs, a landmark multi-center study has found. Read more [tags] Pharmacy News [/tags]
  
  
• Use of nonaspirin NSAIDs during early pregnancy raises risk of miscarriage in women (0)
  The risk of miscarriage is 2.4 times greater for women who took any type and dosage of nonaspirin nonsteroidal anti-inflammatory drugs (NSAIDs) in early pregnancy, according to a University of Montreal study in CMAJ. Read more [tags] Pharmacy News [/tags]
  
  
• Topamax medication during pregnancy can lead to increased risk of oral birth defects in babies (0)
  New data suggest that the drug Topamax and its generic versions increase the risk for the birth defects cleft lip and cleft palate in babies born to women who use the medication during pregnancy, the U.S. Food and Drug Administration said today. Read more [tags] Pharmacy News [/tags]
  
  
• Recombinant human antithrombin drug decreases risk to pregnancy and surgery patients with hereditary antithrombin deficiency (0)
  Pregnancy and surgery patients with a serious blood disorder that causes excessive clotting have responded well to treatment with a man-made anti-clotting protein. Read more [tags] Pharmacy News [/tags]
  
  
• Recombinant human antithrombin drug decreases risk to pregnancy and surgery patients with hereditary antithrombin deficiency (0)
  Pregnancy and surgery patients with a serious blood disorder that causes excessive clotting have responded well to treatment with a man-made anti-clotting protein. Read more [tags] Pharmacy News [/tags]